Treatment of pemphigus and other neglected skin conditions with PC111, a human anti-Fas Ligand monoclonal antibody: a potential disease modifier
Background Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease with high morbidity and mortality, treated mainly with long-term immunosuppressants. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is an acute, life-threatening drug reaction with severe skin and mucosal in...
Saved in:
Main Authors: | Roberta Lotti, Antonino Amato, Brydon Bennett, Tommaso Zanocco-Marani, Alessandra Marconi, Carlo Pincelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2526075 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential Diagnostics of Toxic Epidermal Necrolysis (Lyell’s Syndrome) in ICU: Case Reports
by: Yu. V. Molochkova, et al.
Published: (2022-01-01) -
Multidisciplinary Management of Paraneoplastic Pemphigus Associated with B-Cell Lymphoma: A Case Report
by: Alothman L, et al.
Published: (2025-07-01) -
A 10-Year Observational Study on Treatment Approaches in Pemphigus and Pemphigoid
by: Cristiana Palmela Pereira, et al.
Published: (2025-01-01) -
Role of Desmoglein Autoantibody in the Diagnosis of Pemphigus Vulgaris: A Case Report
by: Diane Lukito Setiawan, et al.
Published: (2025-07-01) -
The Impact of the Adoption of FAS 14/2022 on Business Accounting Processes
by: E. S. Druzhilovskaya, et al.
Published: (2024-06-01)